PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

Thu, 16 Apr 2026 08:37:38 +0000
Intellectual Property

The European Patent Office granted Patent EP3244930A1 to the University of Southern California on April 8, 2026. The patent covers pharmaceutical compositions comprising POH derivatives for therapeutic applications including cancer treatment. The patent is designated across 38 European member states including DE, FR, GB, IT, ES, NL, BE, and others.